AOD9604 6mg
US$ 27.11
ghk cu compound GHK-Cu Scalp Solution GHK-CU – Peptide Foundry
Description
Glutamic acid as a precursor to N terminal pyroglutamic acid in mouse plasmacytoma protein (protein synthesis-initiation-immunoglobulins-pyrrolidone carboxylic acid) Proc
Care is evolving from generalized protocols toward models that are: Personalized Data driven Outcome focused Peptides fit within this model because they can target specific biological pathways, including repair, inflammation, cognition, and metabolism, based on individual need
10.1371/journal.pone.0054014 PLoS One 87 SiegelR
Because all 12 patients scored a 5 on the Global Response Assessment, this therapy was considered successful
